BLOCK-SAH is a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial with a sequential parallel comparison design (SPCD) of bilateral pterygopalatine fossa (PPF) injections with 20mg ropivacaine + 4mg dexamethasone�
- Investigator
- Carolina B Maciel
- Status
- Accepting Candidates
- Ages
- 18 Years - 85 Years
- Sexes
- All